News & Updates
Showing Infectious Diseases articles
Showing

Real-world study favours ritonavir-based regimens for hospitalized COVID-19 patients
In a real-world analysis evaluating four oral antiviral agents for the treatment of COVID-19, two ritonavir-based regimens fared better than molnupiravir and azvudine in reducing hospital stay among patients hospitalized for mild or moderate disease.

Bedaquiline-containing regimens show sustained benefit in rifampicin-resistant TB
In the treatment of patients with rifampicin-resistant tuberculosis (TB), two bedaquiline-containing regimens, namely a 9-month all-oral regimen and a shorter 6-month regimen with 8 weeks of aminoglycoside, maintains superior efficacy to a 9-month injectable regimen through 132 weeks, according to long-term data from the STREAM 2 trial.

Influenza-related complications common in kids with neuropsychiatric comorbidity
Neurologic and psychiatric complications associated with influenza occurs rarely in the paediatric population, but such incidence can be severe and may even lead to hospitalization, suggests a study.

New model predicts HCC risk in noncirrhotic CHB patients
A novel prognostic model based on the viral loads of hepatitis B virus (HBV) demonstrates its utility in predicting and stratifying the risk of hepatocellular carcinoma (HCC) in noncirrhotic patients with chronic hepatitis B (CHB) who are not yet receiving antiviral therapy.




